LAZYDAYS HOLDINGS INC (GORV)

US52110H1005 - Common Stock

1.5  -0.09 (-5.66%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to GORV. GORV was compared to 123 industry peers in the Specialty Retail industry. GORV may be in some trouble as it scores bad on both profitability and health. GORV is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

GORV had negative earnings in the past year.
GORV had a positive operating cash flow in the past year.
In multiple years GORV reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: GORV reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of GORV (-24.11%) is worse than 85.25% of its industry peers.
GORV has a Return On Equity of -125.63%. This is in the lower half of the industry: GORV underperforms 77.87% of its industry peers.
Industry RankSector Rank
ROA -24.11%
ROE -125.63%
ROIC N/A
ROA(3y)2.07%
ROA(5y)1.55%
ROE(3y)-1.1%
ROE(5y)0.31%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

In the last couple of years the Operating Margin of GORV has declined.
GORV's Gross Margin of 18.45% is on the low side compared to the rest of the industry. GORV is outperformed by 83.61% of its industry peers.
In the last couple of years the Gross Margin of GORV has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for GORV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.45%
OM growth 3Y-43.99%
OM growth 5Y-17.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.2%
GM growth 5Y-0.49%

0

2. Health

2.1 Basic Checks

GORV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GORV has more shares outstanding
Compared to 5 years ago, GORV has more shares outstanding
Compared to 1 year ago, GORV has a worse debt to assets ratio.

2.2 Solvency

GORV has an Altman-Z score of 0.95. This is a bad value and indicates that GORV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.95, GORV is doing worse than 73.77% of the companies in the same industry.
GORV has a Debt/Equity ratio of 2.53. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of GORV (2.53) is worse than 72.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.53
Debt/FCF N/A
Altman-Z 0.95
ROIC/WACCN/A
WACC2.58%

2.3 Liquidity

A Current Ratio of 0.78 indicates that GORV may have some problems paying its short term obligations.
GORV has a Current ratio of 0.78. This is amonst the worse of the industry: GORV underperforms 87.70% of its industry peers.
GORV has a Quick Ratio of 0.78. This is a bad value and indicates that GORV is not financially healthy enough and could expect problems in meeting its short term obligations.
GORV's Quick ratio of 0.16 is on the low side compared to the rest of the industry. GORV is outperformed by 90.16% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.16

4

3. Growth

3.1 Past

The earnings per share for GORV have decreased strongly by -7800.00% in the last year.
GORV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.37%.
The Revenue has been growing by 12.23% on average over the past years. This is quite good.
EPS 1Y (TTM)-7800%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1283.33%
Revenue 1Y (TTM)-16.37%
Revenue growth 3Y9.84%
Revenue growth 5Y12.23%
Sales Q2Q%-22.6%

3.2 Future

The Earnings Per Share is expected to grow by 29.84% on average over the next years. This is a very strong growth
Based on estimates for the next years, GORV will show a quite strong growth in Revenue. The Revenue will grow by 11.53% on average per year.
EPS Next Y-118.06%
EPS Next 2Y18.84%
EPS Next 3Y29.84%
EPS Next 5YN/A
Revenue Next Year-10.84%
Revenue Next 2Y-1.87%
Revenue Next 3Y2.3%
Revenue Next 5Y11.53%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GORV. In the last year negative earnings were reported.
Also next year GORV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as GORV's earnings are expected to grow with 29.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.84%
EPS Next 3Y29.84%

0

5. Dividend

5.1 Amount

GORV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LAZYDAYS HOLDINGS INC

NASDAQ:GORV (9/6/2024, 8:17:35 PM)

1.5

-0.09 (-5.66%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap21.11M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.11%
ROE -125.63%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 18.45%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 2.53
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.78
Quick Ratio 0.16
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-7800%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-118.06%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-16.37%
Revenue growth 3Y9.84%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y